Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Pii has announced the launch of Busulfan Injection, 6mg/mL in 10mL vials, in partnership with Athenex Pharmaceuticals, Sungen Pharma and Chemwerth.
read more
AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research.
read more
Iktos announced a collaboration agreement with Merck KGaA, Darmstadt, Germany, where Iktos generative modelling AI will be used to facilitate discovery and design of compounds for Merck KGaA.
read more
Pii announced the FDA has issued their EIRs for both FEI registration numbers (1000513101/3006503102), covering Pii's facilities in Hunt Valley and Cockeysville, MD.
read more
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Cambrex has completed the expansion of a new 150m2 research and development laboratory at its site in Paullo, Milan, Italy.
read more
Wednesday, March 13, 2019
Bal Seal Engineering has achieved USP Class VI compliance for its SP-191 and SP-23 seal materials. It has also achieved ISO 10993-5 compliance for its SP-191, SP-23, and UPC-15 materials.
read more
Wednesday, March 13, 2019
CURE has broadened its DEA license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic CBD.
read more
Wednesday, March 13, 2019
Attorney General Bob Ferguson filed a lawsuit against the three largest distributors of prescription opioids in Washington state, arguing that they failed to alert law enforcement of suspicious opioid orders.
read more
Wednesday, March 13, 2019
The U.S. Food and Drug Administration (FDA) approved a new generic of Diovan (valsartan).
read more
Wednesday, March 13, 2019
SGS welcomed the preliminary data from a controlled human infection trial with FluGen’s investigational M2SR vaccine.
read more
Wednesday, March 13, 2019
Particle Sciences has announced the appointment of Karen Bossert as vice president of operations as part of its ongoing strategy to grow and enhance its manufacturing capabilities.
read more
Ajinomoto Bio-Pharma Services provided an update on several of its capital projects currently underway in both the United States and Belgium.
read more
Crown Bioscience announced a licensing agreement with Charles River International Research Models and Services business.
read more
PCI Clinical Services has announced the appointment of Lisa Spence as Director of Clinical Supply Chain – International Region.
read more